One visit, two shots: new study tests RSV and COVID vaccines together for older adults

NCT ID NCT06374394

First seen Jan 11, 2026 · Last updated Apr 30, 2026 · Updated 15 times

Summary

This study looked at whether giving an RSV vaccine and a COVID-19 booster at the same time is safe and works well in adults aged 50 and older. About 841 people took part. The goal was to see if the immune response was similar to getting the vaccines separately.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • GSK Investigational Site

    Coral Gables, Florida, 33134, United States

  • GSK Investigational Site

    Savannah, Georgia, 31406, United States

  • GSK Investigational Site

    Evansville, Indiana, 47714, United States

  • GSK Investigational Site

    Omaha, Nebraska, 68134, United States

  • GSK Investigational Site

    Rochester, New York, 14609, United States

  • GSK Investigational Site

    Winston-Salem, North Carolina, 27103, United States

  • GSK Investigational Site

    North Charleston, South Carolina, 29405, United States

  • GSK Investigational Site

    Newport News, Virginia, 23606, United States

  • GSK Investigational Site

    Antwerp, 2000, Belgium

  • GSK Investigational Site

    Edegem, 2650, Belgium

  • GSK Investigational Site

    Ghent, 9000, Belgium

  • GSK Investigational Site

    Kluisbergen, 9690, Belgium

  • GSK Investigational Site

    Mechelen, 2800, Belgium

  • GSK Investigational Site

    Breda, 4818 CK, Netherlands

  • GSK Investigational Site

    Enschede, 7512 KZ, Netherlands

  • GSK Investigational Site

    Utrecht, 3584 BA, Netherlands

  • GSK Investigational Site

    Zutphen, 7207 AE, Netherlands

  • GSK Investigational Site

    A Coruña, 15006, Spain

  • GSK Investigational Site

    Barcelona, 08023, Spain

  • GSK Investigational Site

    Barcelona, 08907, Spain

  • GSK Investigational Site

    Boadilla Del Monte Madrid, 28660, Spain

  • GSK Investigational Site

    Madrid, 28040, Spain

  • GSK Investigational Site

    Madrid, 28041, Spain

  • GSK Investigational Site

    Madrid, 28222, Spain

Conditions

Explore the condition pages connected to this study.